Your session is about to expire
← Back to Search
Soft Contact Lens
MiSight 1 Day Contact Lenses for Near-sightedness
N/A
Recruiting
Led By William Gleason, OD
Research Sponsored by CooperVision International Limited (CVIL)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 8 and 12 years of age inclusive at the time of enrollment
Free of ocular disease or abnormalities (including any corneal scar)
Must not have
Acute and subacute inflammation or infection of the anterior chamber of the eye
Any eye disease, injury, or abnormality that affects the cornea, conjunctiva, or eyelids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is meant to study the safety of a new type of contact lens among the people it is intended for.
Who is the study for?
This trial is for children aged 8-12 with near-sightedness, who can wear contact lenses for about 10 hours a day and have good overall eye health. They must not have severe dry eyes, infections, or diseases affecting the eyes and must be able to handle lenses properly.
What is being tested?
The study tests the safety of MiSight 1 Day disposable soft contact lenses in young patients within the US. It aims to confirm that these lenses are safe for daily use among kids who meet specific vision criteria.
What are the potential side effects?
Potential side effects may include discomfort while wearing the contacts, possible allergic reactions to lens material or solutions used with them, and an increased risk of eye infections if proper hygiene isn't followed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 8 and 12 years old.
Select...
My eyes are healthy and free from any diseases or scars.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have recent or ongoing eye inflammation or infection.
Select...
I have an eye condition affecting my cornea, conjunctiva, or eyelids.
Select...
My cornea is less sensitive to touch, and I am not aphakic.
Select...
I suffer from severe dry eyes.
Select...
I do not have an active infection in my eye.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Microbial Keratitis (MK)
Secondary study objectives
Incidence of loss of best-corrected visual acuity
Incidence of non-infectious infiltrative keratitis
Incidence of peripheral infiltrative keratitis/non-infectious ulcers
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: MiSight 1 DayExperimental Treatment1 Intervention
MiSight 1 Day
Find a Location
Who is running the clinical trial?
CooperVision International Limited (CVIL)Lead Sponsor
161 Previous Clinical Trials
11,706 Total Patients Enrolled
Coopervision, Inc.Lead Sponsor
163 Previous Clinical Trials
11,796 Total Patients Enrolled
William Gleason, ODPrincipal InvestigatorForesight Regulatory Strategies
3 Previous Clinical Trials
1,458 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have recent or ongoing eye inflammation or infection.My cornea is less sensitive to touch, and I am not aphakic.I have an eye condition affecting my cornea, conjunctiva, or eyelids.I have a condition that could worsen with contact lens use.I suffer from severe dry eyes.I do not have an active infection in my eye.You have allergies that can be worsened by wearing contact lenses or using contact lens solutions.I am between 8 and 12 years old.I understand the study and agree to my child's anonymous data being used.I am willing to wear contact lenses for about 10 hours daily and 6 days a week.My eyes are healthy and free from any diseases or scars.My eyes are red or irritated.
Research Study Groups:
This trial has the following groups:- Group 1: MiSight 1 Day
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Near-sightedness Patient Testimony for trial: Trial Name: NCT05285527 — N/A